A Phase I, Prospective, Open-Label, Comparison Study of Lymphoseek and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Patients With Known Cancer of the the Endometrium Who Are Undergoing Lymph Node Dissection
Latest Information Update: 22 Oct 2018
At a glance
- Drugs Tc 99m tilmanocept (Primary)
- Indications Endometrial cancer
- Focus Adverse reactions
Most Recent Events
- 10 Oct 2018 Status changed from recruiting to discontinued.
- 06 Jun 2017 Planned End Date changed from 1 Dec 2016 to 1 Nov 2017.
- 06 Jun 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Nov 2017.